Advertisements

Залаин

Quick links to important sections

Залаин

Selected form

Advertisements
Advertisements

Treatment option: Athlete'S Foot

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Залаин

Quick Facts: Залаин (Sertaconazole)

Property Description
Active Ingredient Sertaconazole nitrate
Form Cream; Vaginal Ovules/Suppositories
Pharmacological Class Azole Antifungal / Antimycotic
Common Use Local elimination of fungal infections
Origin Synthetic (Imidazole derivative)

What Type of Medicine is Залаин?

Залаин (Zalain) is a synthetic, broad-spectrum antifungal agent classified as an azole antimycotic. Its primary purpose is to eliminate superficial fungal infections of the skin and mucous membranes locally. The active compound is Sertaconazole, a unique chemical derivative containing both the imidazole and benzothiophene families, a structure that is clinically recognized for its potent fungicidal activity. This chemical foundation confirms the drug’s expertise in targeting a wide variety of fungal pathogens.

Sertaconazole is utilized for both dermatological (D01AC14) and gynecological (G01AF19) anti-infective purposes. This dual classification establishes its identity as a targeted local medication rather than a treatment for systemic conditions.

Composition and Available Forms

The core component of the medicine is Sertaconazole nitrate, which is prepared exclusively for direct application to the affected areas. As a single-ingredient product, it is most commonly supplied in two main forms intended for local routes of administration: as a cream for topical use (e.g., treating common skin mycoses like athlete's foot) and as vaginal ovules or suppositories for gynecological use.

This focus on local administration ensures the medication remains highly concentrated at the infection site. The different forms are designed for patient-specific needs, such as the ovules being formulated with semi-synthetic glycerides to ensure proper delivery to the vaginal mucous membranes.

General Purpose and Mechanism

The general purpose of the medicine is to eradicate the fungus causing the infection by disrupting its structural integrity. Sertaconazole achieves this by inhibiting the synthesis of ergosterol, a vital component necessary for building the fungal cell membrane. The resulting damage destabilizes the fungal cell, leading to its destruction.

This potent fungicidal action is essential to its design, ensuring the complete elimination of the source of the infection, which is the mechanism that provides reliable relief from the associated discomfort and symptoms.

Advertisements

What side effects are possible with Залаин?

Possible Side Effects and Safety Information

The safety profile for Sertaconazole, the active component of Залаин, is primarily characterized by localized reactions at the site of application due to the negligible amount of the medicine absorbed systemically. Most officially documented adverse reactions pertain to the local treatment area, categorized as Skin and Subcutaneous Tissue Disorders or Reproductive System Disorders.

Localized effects such as burning sensation, erythema (redness), pruritus (itching), dry skin, and contact dermatitis have been reported. While the frequency of these common local reactions may be categorized as 'Not Known' in some post-marketing surveillance data, they are the expected manifestations of local intolerance and are generally transient.

Classification of Adverse Reactions
Rare (Ovule use): Headache
Serious Reaction: Hypersensitivity (allergic reaction) to Sertaconazole or other imidazole antifungals, which requires treatment termination.

The official labeling notes specific safety constraints. The cream formulation is strictly for external dermatologic use and must not be used in the eyes. For the vaginal ovule formulation, the product excipients may potentially compromise the integrity or effectiveness of latex or rubber barrier contraceptives.

Regulatory documents outline specific considerations for special populations: caution is advised regarding use during pregnancy and lactation as safety has not been fully established, though systemic absorption is minimal. The safety and effectiveness have not been confirmed in pediatric patients under 12 years of age.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Sertaconazole nitrate, a medication designated strictly for local use, is defined by the absence of systemic overdose reports and negligible drug absorption.

Overdose scope (Official Regulatory Information) Details
Documented overdose presentations Overdosage with the topical or local formulation has not been reported in official regulatory documentation to date.
Physiological systems affected No specific systemic effects are documented. Systemic levels of Sertaconazole measured after repeated topical application are consistently below the limit of quantitation of the analytical method.
Dose/Exposure factors Overdose risk is associated primarily with accidental oral ingestion, as the product is mandated for external or local use only and not for oral use.
When immediate medical help is required Immediate medical attention or professional assistance is required in the event of accidental ingestion of the product, as stated in the prescribing information.

Overdose Classification and Response

The regulatory profile does not include specific severity classifications due to the lack of reported cases. The required emergency action for accidental ingestion is to proceed with symptomatic and supportive treatment, as no specific antidote is known or listed in the official documents. Monitoring and observation are implied as necessary procedures when immediate medical assistance is sought for this non-intended route of exposure.

The text length is approximately 188 words.

Advertisements

Therapeutic Uses of Залаин

What Залаин treats: Main Uses and Benefits

This medication is applied in clinical settings that involve acute or disruptive symptom patterns, and is commonly used to help with a range of superficial fungal issues. Therapeutic applications include mycoses such as athlete’s foot, ringworm, jock itch, and vulvovaginal infections caused by Candida fungi.

The drug is used in situations involving certain distressing symptoms, helping to address symptom clusters that may become intense or disruptive, specifically intense itching, redness, burning, and soreness. In these scenarios, the approach provided supports the patient during difficult episodes by easing distress. The drug's role is to support symptomatic management, which helps patients cope more steadily with these episodes. This assistance helps maintain a sense of stability when symptoms are more noticeable, especially for infections that present with both irritation and microbial activity.


Quick Fact: Relief for Localized Discomfort
Primary Focus: Symptomatic management of itching, burning, and irritation related to fungal infections.
Therapeutic Context: Conditions characterized by periods of heightened localized symptoms on the skin and mucosa.
Patient Benefit: Provides support that helps ease the overall symptom burden and assists with maintaining functional stability.

Regulatory References

  1. Summary of Product Characteristics for Sertaconazole
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Restriction Profile

This section outlines the population eligibility and limitations for Залаин (Sertaconazole) strictly based on official regulatory documentation, such as the FDA Prescribing Information and European Summary of Product Characteristics (SmPC).

Eligibility scope Official Regulatory Statement
Populations for whom use is allowed Adult and pediatric patients 12 years of age and older who are immunocompetent (Topical cream indication).
Populations for whom use is contraindicated Patients with known or suspected hypersensitivity to sertaconazole nitrate or any components in the formulation.
Age-related eligibility rules Safety and effectiveness of the topical cream have not been established in pediatric patients below the age of 12 years.
Pregnancy and lactation eligibility The topical cream is Pregnancy Category C, meaning use is permitted only if the potential benefit justifies the potential risk. Caution is advised during lactation, as excretion into human milk is unknown.
Specific restrictions (Formulation-dependent) The cream formulation is not for ophthalmic, oral, or intravaginal use. The ovule formulation is not recommended for concomitant use with latex contraceptives or spermicidal products due to a risk of damage or inactivation.

Connection to the overall eligibility profile

Regulatory agencies define eligibility primarily through an absolute exclusion for hypersensitivity and a defined minimum age (12 years) for established use of the topical cream. For all other populations, including pregnant women, geriatric patients, and those with renal or hepatic impairment, use is either conditionally permitted after risk evaluation or subject to cautionary limitations due to insufficient clinical data, reflecting the drug's minimal systemic absorption.

Advertisements

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Sertaconazole

The interaction profile of this medicine is largely defined by its negligible systemic absorption following topical or vaginal use, which limits the potential for systemic drug interactions.

Category Official Regulatory Statement
Medicinal product categories with documented interactions Local Contraceptive Methods (Vaginal Barriers/Spermicides)
Specific interacting medicines (if explicitly listed) Spermicides (Category Restriction)
Mechanistic basis of interactions (only if stated in label) Physical degradation and inactivation of local contraceptive methods
Timing-based interaction rules (if applicable) None documented
Population-specific interaction notes (if applicable) None documented
Interaction-related restrictions Concurrent use of contraceptive diaphragms or condoms is not recommended; concomitant use of spermicides is not recommended

Interaction classifications (high-level)

Classification Official Regulatory Statement
Interaction severity classification (as defined in official documents) Local Restriction / Not Recommended
Regulatory basis (EMA / FDA / etc.) European/National Health Authority SmPC; U.S. FDA Prescribing Information
Interaction-context constraints (as defined in official documents) Constraints are limited to the local site of administration (vaginal route)

Resulting interaction structure

Official interaction statements:

  • For the topical cream, the regulatory label states that potential interactions with other systemic drugs or laboratory tests have not been systematically evaluated.
  • Interactions with food, alcohol, or herbal products are not documented in the official prescribing information.
  • Specific restrictions apply to the vaginal ovule formulation, where concurrent use with certain local contraceptive methods is not recommended.
  • This restriction includes barrier methods such as condoms and diaphragms, due to the regulatory-documented risk of physical tearing, and spermicides, due to the risk of inactivation of the contraceptive product.

Connection to the overall interaction profile (2–4 sentences): The official regulatory documents define the product’s interaction structure primarily through its local application, resulting in an absence of warnings for systemic metabolic (CYP) or transporter-mediated interactions. Consequently, there are no documented mandatory timing requirements for administration with other medicines. The only formal restrictions are localized and pertain to the use of barrier contraceptives and spermicides with the vaginal ovule formulation.

Advertisements

Mechanism of Action

The mechanism of action for Залаин (Sertaconazole) is defined by a dual-action strategy that targets the fungal pathogen's essential structures and biochemical processes, resulting in cellular destruction. This strategy is driven by its unique molecular structure, which facilitates two simultaneous actions.

Disruption of Fungal Cell Sterol Synthesis

The drug's primary action involves its imidazole ring, which functions as an enzyme inhibitor. Sertaconazole targets and blocks the lanosterol 14alpha-demethylase enzyme, a key player in the ergosterol biosynthesis pathway. By halting this process, the drug prevents the conversion of precursor sterols into ergosterol, a component necessary for maintaining the fungal cell's membrane fluidity and function. This initiates a cascade where the loss of structural integrity is compounded by the toxic accumulation of abnormal methylated sterols within the cell.

Direct Membrane Structural Damage

In parallel with enzyme inhibition, Sertaconazole exerts a second action through its benzothiophene molecular group. This group physically interacts with and embeds into the fatty acids and structural components of the existing fungal cell membrane. This physical mechanism causes rapid membrane destabilization, leading to increased permeability, leakage of essential cellular contents, and irreparable structural failure. The combined effect of structural failure and biochemical blockade results in a comprehensive fungicidal action, which drives the destruction of the pathogen.

Advertisements

Dosage and Administration Information

The usage pattern for sertaconazole is strictly dependent on the specific formulation and the intended site of administration. The medicine is prepared for local application via two primary, established routes: topical for skin infections (cream) and intravaginal for specific mucous membrane infections (ovule/suppository). It is an explicit instruction that the cream formulation must not be used intravaginally, orally, or in the eyes, as it is designed only for the skin surface.

The high-level dosing regimen follows two distinct protocols:

Administration Form Frequency and Schedule Course Duration
Topical Cream (2%) Applied twice daily (morning and evening). The full course is for 4 weeks to complete the treatment period, regardless of symptom resolution.
Vaginal Ovule (300 mg) Single, one-time dose, typically administered at bedtime. A single-day treatment; a second dose may be administered after 7 days if required for persistent clinical symptoms.

For the topical application, the cream should cover the infected skin and the area immediately surrounding it, ideally after the area has been thoroughly dried. Use of the topical formulation is described for pediatric patients aged 12 years and older, who follow the same twice-daily dosing regimen as adults.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Залаин (Sertaconazole)

Research examining the Sertaconazole cream formulation has primarily involved short-term, randomized controlled trials (RCTs). These studies were designed to explore use in adults with confirmed fungal skin conditions, such as athlete's foot (tinea pedis). Researchers conducted comparisons against an inactive vehicle (placebo) and against other approved topical treatments.

In these trials, research examined two main outcomes: the mycological status (checking for the presence of the fungus itself) and clinical status (monitoring how physical discomfort like itching and scaling changed over time). The findings from these studies describe patterns observed in the treatment groups related to mycological status measurements when compared to the inactive vehicle. Studies also monitored how symptoms evolved, with research highlighting changes measured during the study period.


The evidence base for the Sertaconazole vaginal ovule formulation centers on conditions associated with acute or disruptive episodes of yeast infection. Research mainly involved randomized comparative clinical studies where a single-dose regimen was evaluated against multi-day courses of other established topical antifungal treatments.

These studies explored outcomes related to physical discomfort, such as burning and soreness, and monitored the mycological status. Findings describe patterns observed in the studies where high proportions of participants had mycological status monitored and patient-reported outcomes describing perceived discomfort recorded within the short-term follow-up period.

Research Gaps and Uncertainty

One major limitation is that the research primarily focuses on acute and uncomplicated infections. Long-term effects are not fully established, as follow-up durations were often limited in the pivotal trials. The research mainly involved immunocompetent adults; data for other groups, such as those who are immunocompromised or have recurrent candidiasis, remain insufficient. The findings describe group patterns, not personal outcomes.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Залаин (FAQ)


Q: Is Залаин available without a prescription?

According to official regulatory sources, the cream formulation of sertaconazole (the active ingredient in Залаин) is typically classified as a prescription-only medicine in some regions. This means that, in those regions, the drug generally requires authorization from a healthcare provider before it can be dispensed.


Q: What should I do if I forget to use Залаин?

Guidance from patient information suggests that if it is nearly time for the next scheduled application, the missed dose is typically skipped, and the regular schedule is resumed. The application is then continued at the regular time. Official information generally describes that extra medicine should not be applied to compensate for a missed dose.


Q: Are there any long-term side effects noted for Залаин?

The documented side effects for this medication are primarily local skin reactions, such as irritation, burning, and dryness, which are generally described as transient, meaning they do not last long. Official product documentation does not establish a profile for known, persistent, or systemic long-term effects beyond these expected temporary local reactions.


Q: Does Залаин interact with common vitamins or supplements?

Official regulatory information does not list specific interactions with common vitamins, nutritional supplements, or herbal products. Because of this, some official patient materials include general guidance to inform healthcare providers about all prescription and non-prescription products being used, including supplements.


Q: Is there any research on Залаин's use in children or adolescents?

Official information indicates that the topical cream formulation has been studied in children and has not been shown to cause different side effects or problems compared to use in adults. The established use of the topical cream is defined for pediatric patients who are 12 years of age and older.


Q: Why is Залаин sometimes preferred over other antifungal products?

Research has examined the active ingredient, sertaconazole, and noted that it demonstrated higher antifungal activity in laboratory tests (in vitro) compared to certain other antifungal agents in the same class. This research finding on higher activity is noted in the medical literature when discussing the drug’s profile compared to certain other antifungals in the same class.


Q: Can using Залаин affect future fertility?

The topical cream is categorized as Pregnancy Category C, meaning its use is based on a risk assessment. While systemic absorption is noted as limited and animal studies did not observe adverse effects on reproduction, an explicit, generalized statement on the impact on human fertility is not typically provided in official regulatory summaries.


Q: What should I do if the side effects seem severe?

Official patient instructions describe that if signs of a very bad reaction are noticed—such as blistering, severe redness, swelling, oozing, or symptoms suggesting a serious allergic reaction—it is advised to immediately contact a healthcare provider or seek emergency medical help. This is the regulatory guidance for such events.


Q: Does the efficacy of Залаин change if it's used with soap or certain body washes?

Official patient information suggests that the infected area should be thoroughly washed with soap and water and dried completely before applying the cream. This preparation practice aligns with guidance for topical applications, but there is no regulatory documentation defining an interaction that would change the drug’s overall effectiveness.


Q: Has the main active ingredient in Залаин been studied extensively?

Sertaconazole is described in medical literature as a well-established antifungal agent. The regulatory basis for its approval is founded on multiple randomized controlled trials and clinical studies, confirming its ability to kill fungus (fungicidal activity) against various pathogens.


Q: Is Залаин available in countries other than Russia?

Yes, the active ingredient sertaconazole is marketed under the brand name 'Zalain' and other trade names (e.g., Ertaczo, Onabet) in numerous countries worldwide, as documented in international drug directories. This establishes its global presence.


Q: Does using Залаин prevent recurrence of the infection?

Regulatory guidance emphasizes that the medication must be used for the full treatment time prescribed. When treatment is not completed for the full duration, there is a risk that the infection may not be completely eliminated, which is a factor associated with recurrence.


Q: Is the suppository form messy to use?

The vaginal ovule (suppository) form of this medicine contains inert ingredients called excipients, which are designed to melt within the body to release the active ingredient. This process commonly results in some discharge of the product remnants, which is an expected physical consequence of using this type of formulation.


Q: Can I use Залаин if I have a known allergy to other antifungals?

The official product information advises caution when prescribing this medication to patients known to be sensitive to other antifungal agents in the imidazole family. This is because there is a potential for a similar reaction, known as cross-reactivity, to occur.


Q: What if I accidentally swallow a small amount of the cream?

The cream is strictly designed for external use and should not be swallowed. Should accidental oral exposure occur, official guidance states that one should contact the national poison control center or seek emergency medical assistance immediately.


Q: What does the official information say about Залаин for severe cases?

The topical cream is officially indicated for use in uncomplicated fungal infections, such as interdigital athlete's foot, in patients who are immunocompetent (have a normal immune system). The research evidence summary also notes that studies primarily focus on acute and uncomplicated infections, not severe cases.


Q: Is Залаин effective against all types of fungal infections?

The drug is described as a broad-spectrum antifungal agent, meaning it is active against many types of fungi. However, official labeling specifies the exact microorganisms that cause the fungal infections for which it is indicated, confirming it is not for use against all types of fungal infections.


Q: What is the history or origin of the drug Залаин?

Sertaconazole, the active ingredient, is a synthetic imidazole derivative developed specifically for its antifungal properties. It is notable for containing a benzothiophene ring, a structural feature that differentiates it from other drugs within the azole class of antifungals.


Q: Do regulators require any specific monitoring when using Залаин?

Regulatory guidance advises patients to reassess the diagnosis and seek medical attention if there is no clinical improvement or if the treated condition worsens after a specified period of treatment, such as two weeks for the cream formulation. This is the primary type of monitoring advised in the official documentation.


Q: Is it possible to develop resistance to Залаин over time?

Research has noted that sertaconazole may have properties that can inhibit certain mechanisms of drug resistance observed in laboratory studies. However, a general regulatory statement concerning the long-term development of fungal resistance is not typically provided in standard drug labels.

Advertisements

How should Залаин be stored and disposed of?

The storage and disposal of Залаин (Sertaconazole nitrate) must follow specific regulatory guidelines to maintain product integrity and ensure safety.

Official Storage Conditions

Requirement Condition
Temperature Store at Room Temperature, specifically 20 C to 25 C (68 F to 77 F), with excursions permitted to 15 C to 30 C.
Protection Keep away from excessive heat, moisture, and direct light. Do not store the medicine in the bathroom, and keep it from freezing.
Container Store in the original container, tightly closed.

Disposal and Child Safety

All unused or expired medicine must be kept out of the reach of children. The best method for disposal is using a drug take-back program. If a take-back program is unavailable, dispose of the medicine by mixing it with an undesirable substance (such as coffee grounds or cat litter), placing it in a sealed container, and throwing it in the household trash. Do not flush the product down a toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Залаин found in:

A-Z Index: